Literature DB >> 18600545

Inhibition of deoxynucleoside kinases in human thymocytes prevents dATP accumulation and induction of apoptosis.

Michelle L Joachims1, Patrick Marble, Christopher Knott-Craig, Peter Pastuszko, Michael R Blackburn, Linda F Thompson.   

Abstract

Thymocytes lacking adenosine deaminase (ADA) activity, a purine metabolism enzyme, accumulate intracellular dATP and consequently undergo apoptosis during development. We have analyzed the effect of ADA enzyme inhibition in human thymocyte suspension cultures with regard to accumulation of intracellular dATP and induction of apoptosis. We demonstrate that while inhibition of deoxycytidine kinase will prevent the accumulation of dATP and induction of apoptosis to a large degree, inhibition of both deoxycytidine kinase and adenosine kinase completely abrogates the accumulation of dATP and significantly reduces the induction of apoptosis. Thus, both deoxynucleoside kinases are involved in this model of ADA deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600545      PMCID: PMC2752032          DOI: 10.1080/15257770802146270

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  9 in total

1.  Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.

Authors:  B G Ugarkar; J M DaRe; J J Kopcho; C E Browne; J M Schanzer; J B Wiesner; M D Erion
Journal:  J Med Chem       Date:  2000-07-27       Impact factor: 7.446

2.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

3.  A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells.

Authors:  B Ullman; B B Levinson; M S Hershfield; D W Martin
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

4.  Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures.

Authors:  L F Thompson; C J Van de Wiele; A B Laurent; S W Hooker; J G Vaughn; H Jiang; K Khare; R E Kellems; M R Blackburn; M S Hershfield; R Resta
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 5.  Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.

Authors:  Michael R Blackburn; Rodney E Kellems
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

6.  Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.

Authors:  C Justin Van De Wiele; James G Vaughn; Michael R Blackburn; Catherine A Ledent; Marlene Jacobson; Hong Jiang; Linda F Thompson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

Authors:  D A Carson; D B Wasson; E Lakow; N Kamatani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

Review 9.  Mammalian deoxyribonucleoside kinases.

Authors:  E S Arnér; S Eriksson
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

  9 in total
  4 in total

1.  Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease.

Authors:  Tingting Weng; Harry Karmouty-Quintana; Luis J Garcia-Morales; Jose G Molina; Mesias Pedroza; Raquel R Bunge; Brian A Bruckner; Matthias Loebe; Harish Seethamraju; Michael R Blackburn
Journal:  FASEB J       Date:  2013-02-07       Impact factor: 5.191

2.  Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases.

Authors:  Michelle L Joachims; Patrick A Marble; Aletha B Laurent; Peter Pastuszko; Marco Paliotta; Michael R Blackburn; Linda F Thompson
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

3.  Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy.

Authors:  Federico A Moretti; Giuliana Giardino; Teresa C H Attenborough; Athina Soragia Gkazi; Ben K Margetts; Giancarlo la Marca; Lynette Fairbanks; Tessa Crompton; H Bobby Gaspar
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

4.  Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.

Authors:  Paola de Andrade Mello; Eduardo Cremonese Filippi-Chiela; Jéssica Nascimento; Aline Beckenkamp; Danielle Bertodo Santana; Franciele Kipper; Emerson André Casali; Alessandra Nejar Bruno; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Marcia Rosângela Wink; Guido Lenz; Andréia Buffon
Journal:  Mol Biol Cell       Date:  2014-08-07       Impact factor: 4.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.